$35.00
0.310.89%
Last update: 9:30 AM
15 minutes delayed
Comments
Loading...
QuidelOrtho
QDELNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
QuidelOrtho (NASDAQ:QDEL) Stock, Analyst Ratings, Price Targets, Forecasts
QuidelOrtho Corp has a consensus price target of $63.5 based on the ratings of 8 analysts. The high is $86 issued by UBS on October 14, 2022. The low is $37 issued by JP Morgan on February 14, 2024. The 3 most-recent analyst ratings were released by RBC Capital, UBS, and RBC Capital on May 9, 2024, March 4, 2024, and February 14, 2024, respectively. With an average price target of $63.67 between RBC Capital, UBS, and RBC Capital, there's an implied 81.90% upside for QuidelOrtho Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
UBS
Raymond James
JP Morgan
Citigroup
1calculated from analyst ratings
Analyst Ratings for QuidelOrtho
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | Buy Now | 94.29% | RBC Capital | Conor McNamara | $81 → $68 | Maintains | Outperform | Get Alert |
| 03/04/2024 | Buy Now | 20% | UBS | John Sourbeer | $70 → $42 | Downgrade | Neutral → Sell | Get Alert |
| 02/14/2024 | Buy Now | — | Craig-Hallum | Alexander Nowak | — | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | Buy Now | 131.43% | RBC Capital | Conor McNamara | $130 → $81 | Maintains | Outperform | Get Alert |
| 02/14/2024 | Buy Now | 117.14% | Raymond James | Andrew Cooper | $100 → $76 | Downgrade | Strong Buy → Outperform | Get Alert |
| 02/14/2024 | Buy Now | — | William Blair | Andrew Brackmann | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/14/2024 | Buy Now | 5.71% | JP Morgan | Casey Woodring | $66 → $37 | Downgrade | Neutral → Underweight | Get Alert |
| 12/21/2023 | Buy Now | 271.43% | RBC Capital | Conor McNamara | $140 → $130 | Maintains | Outperform | Get Alert |
| 12/11/2023 | Buy Now | 105.71% | Citigroup | Patrick Donnelly | $95 → $72 | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | Buy Now | 185.71% | Raymond James | Andrew Cooper | $110 → $100 | Maintains | Strong Buy | Get Alert |
| 09/19/2023 | Buy Now | 300% | RBC Capital | Conor McNamara | → $140 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | Buy Now | 214.29% | Raymond James | Andrew Cooper | $130 → $110 | Maintains | Strong Buy | Get Alert |
| 08/09/2023 | Buy Now | 142.86% | JP Morgan | Casey Woodring | $91 → $85 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 288.57% | RBC Capital | Conor McNamara | → $136 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 280% | RBC Capital | Conor McNamara | $130 → $133 | Maintains | Outperform | Get Alert |
| 02/16/2023 | Buy Now | 288.57% | RBC Capital | Conor McNamara | $125 → $136 | Maintains | Outperform | Get Alert |
| 02/16/2023 | Buy Now | 271.43% | Raymond James | Andrew Cooper | $136 → $130 | Maintains | Strong Buy | Get Alert |
| 12/12/2022 | Buy Now | 257.14% | Citigroup | Patrick Donnelly | $90 → $125 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2022 | Buy Now | 257.14% | RBC Capital | Conor McNamara | → $125 | Initiates | → Outperform | Get Alert |
| 11/03/2022 | Buy Now | 165.71% | JP Morgan | Casey Woodring | $100 → $93 | Maintains | Neutral | Get Alert |
| 10/14/2022 | Buy Now | 145.71% | UBS | Elizabeth Garcia | → $86 | Upgrade | Sell → Neutral | Get Alert |
| 09/19/2022 | Buy Now | 157.14% | Citigroup | Patrick Donnelly | → $90 | Initiates | → Neutral | Get Alert |
| 07/20/2022 | Buy Now | 145.71% | UBS | Elizabeth Garcia | → $86 | Initiates | → Sell | Get Alert |
| 05/06/2022 | Buy Now | 288.57% | Raymond James | Andrew Cooper | $130 → $136 | Maintains | Strong Buy | Get Alert |
| 02/22/2022 | Buy Now | 271.43% | Raymond James | Andrew Cooper | $155 → $130 | Upgrade | Outperform → Strong Buy | Get Alert |
| 08/06/2021 | Buy Now | 342.86% | Raymond James | Andrew Cooper | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for QuidelOrtho (QDEL) stock?
The latest price target for QuidelOrtho (NASDAQ:QDEL) was reported by RBC Capital on May 9, 2024. The analyst firm set a price target for $68.00 expecting QDEL to rise to within 12 months (a possible 94.29% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for QuidelOrtho (QDEL)?
The latest analyst rating for QuidelOrtho (NASDAQ:QDEL) was provided by RBC Capital, and QuidelOrtho maintained their outperform rating.
When was the last upgrade for QuidelOrtho (QDEL)?
The last upgrade for QuidelOrtho Corp happened on December 12, 2022 when Citigroup raised their price target to $125. Citigroup previously had a neutral for QuidelOrtho Corp.
When was the last downgrade for QuidelOrtho (QDEL)?
The last downgrade for QuidelOrtho Corp happened on March 4, 2024 when UBS changed their price target from $70 to $42 for QuidelOrtho Corp.
When is the next analyst rating going to be posted or updated for QuidelOrtho (QDEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuidelOrtho, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuidelOrtho was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
Is the Analyst Rating QuidelOrtho (QDEL) correct?
While ratings are subjective and will change, the latest QuidelOrtho (QDEL) rating was a maintained with a price target of $81.00 to $68.00. The current price QuidelOrtho (QDEL) is trading at is $35.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.